Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 7Colorectal Neoplasms 6Colonic Neoplasms 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Polycystic Ovary Syndrome 2Ovarian Neoplasms 2Leiomyoma 2Endometrial Neoplasms 2Colonic Polyps 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Adenoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Sezary Syndrome 1Pseudotumor Cerebri 1Proteinuria 1Prostate cancer, familial 1Patients With Prostate Cancer 1Patient Preference 1Patient Compliance 1Papillomavirus Infections 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Healthy 1Genital Neoplasms, Female 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Observational × Proteinuria × Clear all
NCT00849394 2012-11-01

Evaluation of Protein in the Urine in Patients Receiving Bevacizumab

North Texas Veterans Healthcare System

Completed
106 enrolled
Gastrointestinal

Colonic Neoplasms, Proteinuria, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡